- Home
- MEDP vs PSO Comparison
MEDP vs PSO Comparison
Compare MEDP & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- PSO
- Stock Information
- Founded
- MEDP 1992
- PSO 1844
- Country
- MEDP United States
- PSO United Kingdom
- Employees
- MEDP N/A
- PSO N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- PSO Books
- Sector
- MEDP Health Care
- PSO Consumer Discretionary
- Exchange
- MEDP Nasdaq
- PSO Nasdaq
- Market Cap
- MEDP 11.7B
- PSO 10.2B
- IPO Year
- MEDP 2016
- PSO 2000
- Fundamental
- Price
- MEDP $311.80
- PSO $15.02
- Analyst Decision
- MEDP Buy
- PSO
- Analyst Count
- MEDP 10
- PSO 0
- Target Price
- MEDP $388.44
- PSO N/A
- AVG Volume (30 Days)
- MEDP 442.3K
- PSO 400.2K
- Earning Date
- MEDP 10-21-2024
- PSO 01-01-0001
- Dividend Yield
- MEDP N/A
- PSO 1.96%
- EPS Growth
- MEDP 33.84
- PSO 23.43
- EPS
- MEDP 11.42
- PSO 0.63
- Revenue
- MEDP $2,070,866,000.00
- PSO $4,485,194,688.00
- Revenue This Year
- MEDP $14.01
- PSO N/A
- Revenue Next Year
- MEDP $5.86
- PSO $3.62
- P/E Ratio
- MEDP $27.19
- PSO $22.66
- Revenue Growth
- MEDP 16.24
- PSO N/A
- 52 Week Low
- MEDP $268.80
- PSO $11.64
- 52 Week High
- MEDP $459.77
- PSO $15.65
- Technical
- Relative Strength Index (RSI)
- MEDP 40.35
- PSO 61.93
- Support Level
- MEDP $356.36
- PSO $15.03
- Resistance Level
- MEDP $366.98
- PSO $15.65
- Average True Range (ATR)
- MEDP 12.77
- PSO 0.17
- MACD
- MEDP 0.39
- PSO 0.00
- Stochastic Oscillator
- MEDP 17.30
- PSO 55.32
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About PSO Pearson Plc
U.K.-listed Pearson is the world's largest educational provider. The company has been disposing of noncore businesses such as the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider. While Pearson's primary activity centres on higher-level education, the firm also has significant operations in providing clinical assessments, professional certification and testing.